| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/21/2007 | US7259015 Vector system |
| 08/21/2007 | US7259014 Fusion protein delivery system and uses thereof |
| 08/21/2007 | US7259009 Self-rearranging DNA vectors |
| 08/21/2007 | US7258992 Reacting biological sample with a multiple epitope fusion polypeptide, detecting the presence or absence of complex, and thereby detecting the presence or absence of Streptococcus antibodies in sample |
| 08/21/2007 | US7258991 Antibody to bladder cancer nuclear matrix protein and its use |
| 08/21/2007 | US7258973 Oligonucleotide sequences for use in the diagnosis and treatment of colon cancer |
| 08/21/2007 | US7258854 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 08/21/2007 | CA2222425C Immortalization and disimmortalization of cells |
| 08/21/2007 | CA2196419C Improvements in or relating to binding proteins for recognition of dna |
| 08/16/2007 | WO2007092944A2 Compositions and methods involving gene therapy and proteasome modulation |
| 08/16/2007 | WO2007091681A1 Radiotherapy enhancing agent in radiotherapy for tumor |
| 08/16/2007 | WO2007091644A1 Fungal growth inhibitor |
| 08/16/2007 | WO2007091066A1 Applications of non-integrating lentiviral vectors |
| 08/16/2007 | WO2007090870A1 Process for preparing a particle comprising a biological molecule and a carrier polymer |
| 08/16/2007 | WO2007090807A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 08/16/2007 | WO2007031091A3 Rna antagonist compounds for the modulation of p21 ras expression |
| 08/16/2007 | WO2007000292A3 Novel targets and compounds useful in the treatment and/or prophylaxis of a cardiovascular disorder, dyslipidemia and atherosclerosis, and methods to identify such compounds |
| 08/16/2007 | WO2006130525A3 Methods for immunotherapy of cancer |
| 08/16/2007 | WO2004091609A3 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 08/16/2007 | WO2004071461A3 Tra16 a tr4/tr2 repressor |
| 08/16/2007 | WO2004064763A3 Cleavage of serum response factor in cardiac diagnosis and therapy |
| 08/16/2007 | WO2004060302A3 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 08/16/2007 | WO2004041778A3 A method for increasing synaptic growth or plasticity |
| 08/16/2007 | WO2002083916A8 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 08/16/2007 | US20070192887 TAT-042 and methods of assessing and treating cancer |
| 08/16/2007 | US20070192886 TAT-044 and methods of assessing and treating cancer |
| 08/16/2007 | US20070192884 TAT-038 and methods of assessing and treating cancer |
| 08/16/2007 | US20070192883 TAT-028 and methods of assessing and treating cancer |
| 08/16/2007 | US20070192882 Hereditary angioedema type III |
| 08/16/2007 | US20070192880 Horming response element binding transregulators |
| 08/16/2007 | US20070191300 selectively modulating NF (Nuclear Factor)- kappa B dependent gene transcription in a cell comprised of modulating I kappa B kinase (IKK) alpha protein activity in the cell |
| 08/16/2007 | US20070191299 Extension Of The Expression of Transgenic Proteins By Immunomodulation |
| 08/16/2007 | US20070191298 Beta Secretase Genes |
| 08/16/2007 | US20070191297 Methods of treating and monitoring systemic lupus erythematosus in individuals |
| 08/16/2007 | US20070191296 Diagnostics and therapeutics for diseases associated with kallikrein 13 (klk13) |
| 08/16/2007 | US20070191295 Gene silencing by systemic rna interference |
| 08/16/2007 | US20070191294 Short interfering rna (sirna) analogues |
| 08/16/2007 | US20070191281 Compound containing a labile disulfide bond |
| 08/16/2007 | US20070191273 Modulation of angiogenesis |
| 08/16/2007 | US20070191263 Valency platform molecules comprising aminooxy groups |
| 08/16/2007 | US20070191262 Cancer Therapy and Prevention Based on Modulation of Complement activity |
| 08/16/2007 | US20070190612 31 Human Secreted Proteins |
| 08/16/2007 | US20070190576 Mitogenic oxygenase regulators |
| 08/16/2007 | US20070190561 Nucleotide sequences coding polymerase for use in identifying modulators to treat cell proliferative disorders; enzyme inhibitors; antitumor agents |
| 08/16/2007 | US20070190158 Pharmaceutical compositions in particulate form |
| 08/16/2007 | US20070190155 Molecular programming of nanoparticle systems for an ordered and controlled sequence of events for gene-drug delivery |
| 08/16/2007 | US20070190128 Suitable for favoring the intracellular delivery of pharmacologically active compounds, facilitating their transmembrane transport, or for promoting their interaction with specific cell membrane sites (receptors) |
| 08/16/2007 | US20070190107 Cell selective implant surface with controlled release of bioactive agents |
| 08/16/2007 | US20070190080 Non-aqueous compositions for oral delivery of insoluble bioactive agents |
| 08/16/2007 | US20070190074 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 08/16/2007 | US20070190073 Bioconjugation; stimulates production of Th1-associated cytokines, lymphocytes, suppresses production of allergen-specific antibodies, reduces allergen-stimulated IgE production |
| 08/16/2007 | US20070190056 Muscle regeneration compositions and uses therefor |
| 08/16/2007 | US20070190055 CCR3 inhibition for ocular angiogenesis and macular degeneration |
| 08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
| 08/16/2007 | US20070190051 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 08/16/2007 | US20070190040 Recombinant p53 adenovirus methods and compositions |
| 08/16/2007 | US20070190039 Novel cell lines, and methods of preparation and use thereof |
| 08/16/2007 | US20070190032 Use of Local Immune Suppression to Enhance Oncolytic Viral Therapy |
| 08/16/2007 | US20070190031 Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to hiv |
| 08/16/2007 | US20070190030 Method of treating arthritis using lentiviral vectors in gene therapy |
| 08/16/2007 | US20070190029 Listeria-induced immunorecruitment and activation, and methods of use thereof |
| 08/16/2007 | US20070190028 Method and apparatus for heat or electromagnetic control of gene expression |
| 08/16/2007 | US20070190027 Contacting the target cell with a recombinant HSV particle comprising an altered gD forming a fusion with a peptide ligand to a receptor specific to the cell wherein the altered gD exhibits reduced binding to at least one of the cellular receptors of wild type gD; cell imaging; gene therapy; kits |
| 08/16/2007 | US20070190024 Il-11 muteins |
| 08/16/2007 | US20070190023 Methods and compositions for modulating the mobilization of stem cells |
| 08/16/2007 | US20070189981 Porphorymonas gingivalis polypeptides and nucleotides |
| 08/16/2007 | DE19720839B4 Baukastenprinzip-Technologie zur Herstellung von langen, exakten DNA-Konstrukten in vitro, insbesondere für die Herstellung von Konstrukten zur Erzeugung von künstlichen Chromosomen (MAC, mammalian artificial chromosome) aus zwei stabil klonierten DNA-Komponenten und der ditelomerische Vektor-Prototyp PTAT Modular system technology for the production of long, exact DNA constructs in vitro, in particular for the preparation of constructs for the production of artificial chromosomes (MAC, mammalian artificial chromosome) of two stable cloned DNA components and the prototype vector ditelomerische PTAT |
| 08/16/2007 | CA2641310A1 Igf-ir antagonists as adjuvants for treatment of prostate cancer |
| 08/16/2007 | CA2638906A1 Rna interference agents for therapeutic use |
| 08/16/2007 | CA2638889A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 08/16/2007 | CA2636632A1 Novel viral vector |
| 08/15/2007 | EP1818409A1 Transfer of mRNAusing polycationic compounds |
| 08/15/2007 | EP1818408A1 Serotype of adenovirus and uses thereof |
| 08/15/2007 | EP1818407A2 Improved regulatory elements for delivery to the liver |
| 08/15/2007 | EP1818341A2 Sheep lice, bovicula ovis, allergen treatment |
| 08/15/2007 | EP1818054A1 Use of a gadolinium chelate for labeling cells |
| 08/15/2007 | EP1817422A2 Viral vectors |
| 08/15/2007 | EP1817416A2 Compositions for treating respiratory viral infections and their use |
| 08/15/2007 | EP1817415A2 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN AND INTERLEUKIN RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/15/2007 | EP1817411A2 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
| 08/15/2007 | EP1817348A1 Per-6-guanidino-, -aminoalkylamino-and -guanidino-alkylamino-cyclodextrins, methods of their synthesis and their use for the compaction of dna and interacellular delivery |
| 08/15/2007 | EP1817060A2 Mda-7 protein variants having antiproliferative activity |
| 08/15/2007 | EP1272614B1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/15/2007 | EP1238070B1 Therapeutically useful synthetic oligonucleotides |
| 08/15/2007 | EP1137785B1 STREPTOCOCCAL C5a PEPTIDASE VACCINE |
| 08/15/2007 | EP1108023B1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 08/15/2007 | EP0752874B1 Enhanced virus-mediated dna transfer |
| 08/15/2007 | CN1332032C Methods of expressing LIM mineralization protein in non-osseous cells |
| 08/15/2007 | CN1332026C Method and device for treating sample and reagent |
| 08/15/2007 | CN101018562A NELL peptide expression systems and bone formation activity of NELL peptide |
| 08/15/2007 | CN101018541A Controlled and sustained delivery of nucleic acid-based therapeutic agents |
| 08/15/2007 | CN101016537A Artificial recombination selection replication type adenovirus and application |
| 08/15/2007 | CN101016324A Nucleic acid molecule RTN4BSR62 and application in preparation of anti-cancer drugs |
| 08/15/2007 | CN101015696A Antisense oligonucleotide-carbon nanotube medicament vector |
| 08/14/2007 | US7256321 Intracellular modulators of apoptopic cell death pathways |
| 08/14/2007 | US7256277 Nucleotide and protein sequence of mammastatin and methods of use |
| 08/14/2007 | US7256274 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 08/14/2007 | US7256267 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 08/14/2007 | US7256263 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies |
| 08/14/2007 | US7256182 Gene delivery compositions and methods |